🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Acquiring Traction Via Social Media

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed weight-reducing properties. Followers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

Based on TikTok, the platform has taken down problematic content and banned related keywords and query recommendations. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.

Within moments of entering one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Details and Pricing

Within these communities, posts display dark colored packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are extremely risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already encountered individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject users to possibly serious health risks”.